X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-reports-development-relating-to-its-disputes-with-juventas-302110387.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-fourth-quarter-and-full-year-2023-business-and-financial-results-302101142.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-report-positive-interim-phase-1-data-for-bi-1206-in-the-treatment-of-relapsedrefractory-indolent-non-hodgkins-lymphoma-in-china-302079474.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-first-dosing-of-folotyn-in-china-302063676.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-third-quarter-2023-business-and-financial-updates-301986119.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-market-approval-of-cnct19-by-china-nmpa-301981482.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-second-quarter-2023-business-and-financial-updates-301898463.html
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-acquires-global-intellectual-property-rights-to-cleave-therapeutics-vcpp97-inhibitor-cb-5339-301881595.html
https://endpts.com/biontech-inks-cancer-deal-with-chinese-biotech-eikon-casi-buy-cleave-therapeutics-assets/
https://www.prnewswire.com/news-releases/casi-pharmaceuticals-announces-first-quarter-2023-financial-results-301827221.html
Market Place
Share 
